GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Overexpression of GSK3β in transgenic mice induces learning deficits and some features associated with Alzheimer's disease (AD), including dentate gyrus (DG) atrophy. Here, we assessed whether these mice also recapitulate DG atrophy as well as impaired neurogenesis reported in AD. Ultrastructural analysis revealed that there were fewer and more disorganized neurogenic niches in these animals, coupled with an increase in the proportion of immature neurons. Indeed, the maturation of granule cells is delayed as witnessed by the alterations to the length and patterning of their dendritic trees and to the mossy fiber terminals. Together with an increase in neuronal death, these phenomena lead to a marked decrease in the number and disorganization of granule cells of the DG. Our results suggest that GSK3β overexpression perturbs proliferation and maturation, resulting in the loss of immature neurons. In turn, the activation of microglia is stimulated in conjunction with a decrease in the birth of new functional neurons, leading to the deterioration of this structure. These data support the idea that by inducing degeneration of the DG, GSK3β could be involved in the pathogenesis of AD. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Kuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“…susceptible to mutation are those encoding presenilin 1 and presenilin 2 (PS-1 and PS-2), the mutation of which may also increase GSK3b activity (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Duff et al., 1996; Takashima et al., 1996; Price and Sisodia, 1998; Baki et…”
BackgroundRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 1×
“…are those encoding presenilin 1 and presenilin 2 (PS-1 and PS-2), the mutation of which may also increase GSK3b activity (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Duff et al., 1996; Takashima et al., 1996; Price and Sisodia, 1998; Baki et al., 2004; Kimura et al.,…”
BackgroundDistinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus
Zhao, C., Teng, E. M., Summers, R. G., Ming, G.-L., & Gage, F. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3648-05.2006 · Cited by 1,257
Experience-Induced Neurogenesis in the Senescent Dentate Gyrus
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03206.1998 · Cited by 1,150 · cited 1×
“…of the neurogenesis declines with age, raising the possibility that reduced neurogenesis may account, to some degree, for the impaired learning and memory and cognitive deterioration in the elderly (Seki and Arai, 1995; Kuhn et al., 1996; Tropepe et al., 1997; Kempermann et al., 1998, 2002).”
BackgroundIncreased hippocampal neurogenesis in Alzheimer's disease
Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634794100 · Cited by 971 · cited 1×
“VC 2010 WILEY-LISS, INC. whether the process of neurogenesis is altered in the disease and thus contributes to cognitive impairment (Chuang,; Jin et al., 2001; Jin et al., 2004; Li et al., 2008; Lazarov and Marr, 2009).”
BackgroundKempermann, G., Gast, D., & Gage, F. H. (2002) · Annals of Neurology · doi:10.1002/ana.10262 · Cited by 889 · cited 1×
“…of the neurogenesis declines with age, raising the possibility that reduced neurogenesis may account, to some degree, for the impaired learning and memory and cognitive deterioration in the elderly (Seki and Arai, 1995; Kuhn et al., 1996; Tropepe et al., 1997; Kempermann et al., 1998, 2002).”
BackgroundFluoxetine targets early progenitor cells in the adult brain
Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637
Disrupted-In-Schizophrenia 1 Regulates Integration of Newly Generated Neurons in the Adult Brain
Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., Liu, X.-B., Yang, C.-H., Jordan, J. D., Ma, D. K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.010 · Cited by 611 · cited 2×
“cell cycle and blocking maturation (Adachi et al., 2007; Duan et al., 2007; He and Shen, 2009; Mao et al., 2009).”
Backgroundβ-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · cited 1×
“This Ab peptide inhibits signal transduction cascades common to the insulin receptor or Wnt pathways, in both cases, resulting in an increase of GSK3b activity (Busciglio et al., 1995; Ferreira et al., 1997; Takashima et al., 1998; Townsend et al., 2007; Magdesian et al., 2008).”
BackgroundHernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Self-citationSoluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway
Townsend, M., Mehta, T., & Selkoe, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610390200 · Cited by 318 · cited 3×
“the APP, PS-1, and PS-2 proteins promote the onset of the disease (Price and Sisodia, 1998), which is associated with an increase in GSK3b activity (Baki et al., 2004; Avila, 2006; Kimura et al., 2007; Townsend et al., 2007).”
BackgroundBattista, D., Ferrari, C. C., Gage, F. H., & Pitossi, F. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04539.x · Cited by 306 · cited 1×
“Continuous astrocyte proliferation leads to the depletion of astrocytes and the neurogenic niche (Battista et al., 2006; Choi et al., 2008a,b).”
BackgroundTakashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · cited 1×
“…those encoding presenilin 1 and presenilin 2 (PS-1 and PS-2), the mutation of which may also increase GSK3b activity (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Duff et al., 1996; Takashima et al., 1996; Price and Sisodia, 1998; Baki et al., 2004; Kimura et al., 2007).”
BackgroundFailure of Neuronal Maturation in Alzheimer Disease Dentate Gyrus
Li, B., Yamamori, H., Tatebayashi, Y., Shafit-Zagardo, B., Tanimukai, H., Chen, S., Iqbal, K., & Grundke-Iqbal, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318160c5db · Cited by 234 · cited 1×
“VC 2010 WILEY-LISS, INC. whether the process of neurogenesis is altered in the disease and thus contributes to cognitive impairment (Chuang,; Jin et al., 2001; Jin et al., 2004; Li et al., 2008; Lazarov and Marr, 2009).”
BackgroundKimura, T., Yamashita, S., Fukuda, T., Park, J., Murayama, M., Mizoroki, T., Yoshiike, Y., Sahara, N., & Takashima, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601917 · Cited by 144 · cited 3×
“…those encoding presenilin 1 and presenilin 2 (PS-1 and PS-2), the mutation of which may also increase GSK3b activity (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Duff et al., 1996; Takashima et al., 1996; Price and Sisodia, 1998; Baki et al., 2004; Kimura et al., 2007).”
BackgroundAssociation of GSK3B with Alzheimer disease and frontotemporal dementia
Schaffer, B. A. J., Bertram, L., Miller, B. L., Mullin, K., Weintraub, S., Johnson, N., Bigio, E. H., Mesulam, M., Wiedau-Pazos, M., Jackson, G. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1368 · Cited by 100 · cited 2×
“Also, GSK3b has been associated with the risk of AD (Schaffer et al., 2008).”
BackgroundMaking sense of the multiple MAP-2 transcripts and their role in the neuron
Shafit-Zagardo, B., & Kalcheva, N. (1998) · Molecular Neurobiology · doi:10.1007/bf02740642 · Cited by 89 · cited 1×
“MAP2, a heat-stable phosphoprotein predominantly expressed in the cell body and dendrites of neurons (Shafit-Zagardo and Kalcheva, 1998; Sanchez et al., 2000a) that is also a substrate for GSK3b (Sanchez et al., 2000b).”
Background
Cited by
Glycogen synthase kinase-3 signaling in Alzheimer's disease
Lauretti, E., Dincer, O., & Praticò, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118664 · Cited by 615
GSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
Self-citationGSK-3 and tau: a key duet in Alzheimer’s disease
Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314
“tion of newborn neurons, delay in the switching-off of doublecortin expression, as well as alteration in the survival and death rates of immature precursors [132].”
BackgroundSelf-citationThe role of dopamine signaling in epileptogenesis
Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199
“GSK-3β hyperactivity is known to induce hippocampal neurodegeneration (Lucas et al., 2001; Sirerol-Piquer et al., 2011; Llorens-Martín et al., 2013), through mechanisms involving the blockade of the pro-survival β-catenin pathway (De Ferrari and Inestrosa,2000) as well as the activation of the mTOR…”
Neuroinflammation and neurogenesis in Alzheimer's disease and potential therapeutic approaches
Sung, P.-S., Lin, P.-Y., Liu, C.-H., Su, H.-C., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030701 · Cited by 193
“The alteration of GSK-3β activity in the dentate gyrus could underlie the alterations in tau phosphorylation in these neurogenic niches of the brains [150].”
Background
Metadata
- Authors
- Sirerol‐Piquer, M., Gomez‐Ramos, P., Hernández, F., Perez, M., Morán, M. A., Fuster‐Matanzo, A., Lucas, J. J., Avila, J., & García‐Verdugo, J. M.
- Venue
- Hippocampus
- Publisher
- Wiley
- Published
- 2011-07-22
- Volume
- 21
- Issue
- 8
- Pages
- 910-922
- ISSN
- 1050-9631 (ISSN-L)
- 1098-1063
- OpenAlex
- W2077551977
- Cited by
- 81
- References
- 19
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.